Position in RPRX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$57,137,067
+$13,651,611 QoQ
Shares Held
1,191,100
+5.8% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss National Bank holds $1,641,068,484 across 148 Biotechnology names. RPRX ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,600 | $332,493,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
303,140 | $234,218,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
387,720 | $128,284,916 | |
| 4 | INSM |
INSMED Inc
|
625,912 | $102,349,130 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
1,191,100 | $57,137,067 | |
| 6 | INCY |
Incyte Corp
|
489,774 | $46,097,528 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
425,431 | $41,373,164 | |
| 8 | MRNA |
Moderna, Inc.
|
696,100 | $35,361,880 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,137,067 | 1,191,100 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $43,485,456 | 1,125,400 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $38,568,096 | 1,093,200 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $40,180,656 | 1,115,200 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $33,156,563 | 1,065,100 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $27,451,311 | 1,076,100 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $32,267,574 | 1,140,600 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $29,629,332 | 1,123,600 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $34,530,690 | 1,137,000 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $33,516,988 | 1,193,200 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $33,260,070 | 1,225,500 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $41,815,622 | 1,360,300 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $50,456,412 | 1,400,400 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $56,169,776 | 1,421,300 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $60,640,057 | 1,509,210 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $63,165,520 | 1,502,510 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $57,984,557 | 1,488,310 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $51,745,623 | 1,298,510 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $25,262,221 | 699,010 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $29,287,764 | 714,510 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $29,299,554 | 671,700 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $21,496,475 | 429,500 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||